GSK vs LPTH · P/E 13, $103.31B cap vs rev $37.2M
GlaxoSmithKline PLC ADR (GSK) versus LightPath Technologies Inc (LPTH) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
LightPath Technologies Inc (LPTH) is a electronic components company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LPTH revenue for 2025-06-30 was $37.2M. Net income was -$14.9M. LPTH currently screens at market cap $980.8M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LPTH currently screens at market cap $980.8M.
Not investment advice. Open the GSK and LPTH stock pages for the full models.
Not investment advice.